Kyntra Bio(DE:1FG0)
€1.47-0.10 (-6.37%)
DE:1FG0
Kyntra Bio earnings date
€1.47
At close:-0.10 (-6.37%)
Kyntra Bio (1FG0) Q2 2026 Earnings Report
1 Followers
DE:1FG0 Q2 2026 EPS Results
- Actual EPS
- EUR 2.69
- Consensus EPS
- -EUR 2.90
- Beat/Miss
- Beat by +EUR 5.59
- One Year Ago EPS
- -EUR 1.71
DE:1FG0 Q2 2026 Revenue Results
- Actual Revenue
- -EUR 1.34M
- Expected Revenue
- EUR 1.90M
- Beat/Miss
- Missed by -EUR 3.24M
- YoY Revenue Growth
- -209.35%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/13/2026
- Time
- After Close
- Conference Call
- Thursday, August 13, 2026
DE:1FG0 Upcoming Earnings
Kyntra Bio's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:1FG0 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:1FG0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -2.01- | -3.19 | ― | ― |
| Nov 16, 2026 | 2026 (Q3) | ―0.04 | 45.12 | -99.92% (-45.09) | |
| Aug 13, 2026 | 2026 (Q2) | -2.902.69 | -1.71 | 257.45% (+4.40) | |
| May 11, 2026 | 2026 (Q1) | -3.05-3.42 | 1.14 | -400.80% (-4.56) | |
| Mar 16, 2026 | 2025 (Q4) | -3.53-3.19 | 4.09 | -178.00% (-7.29) | |
| Nov 10, 2025 | 2025 (Q3) | -3.6445.12 | -3.87 | 1267.29% (+48.99) | |
| Aug 11, 2025 | 2025 (Q2) | -2.09-1.71 | -3.64 | 53.00% (+1.93) | |
| May 12, 2025 | 2025 (Q1) | 0.681.14 | -7.5 | 115.15% (+8.64) | |
| Mar 17, 2025 | 2024 (Q4) | -3.184.09 | -12.96 | 131.58% (+17.05) | |
| Nov 12, 2024 | 2024 (Q3) | -6.97-3.87 | -14.78 | 73.85% (+10.91) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


